Respiratory Treatment Articles & Analysis
16 news found
Recent advances in the fight against severe acute inflammatory lung diseases, including COVID-19, have revealed a promising new approach to treating pulmonary hyperinflammation and long-term lung damage such as fibrosis. A groundbreaking study has developed a first-in-class, carbohydrate-coupled inhibitor of microRNA-21 (RCS-21), which shows significant potential as a therapeutic agent. This ...
Funding from the grant will be used to further the development of ENA001, Enalare's unique agnostic respiratory stimulant for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting. ...
Broncholab™, developed and implemented by Fluidda, is a platform where CT-scan data of individual persons can be uploaded and analyzed with FRI-technology. The result of this analysis is then sent to the attending physician alone, observing all privacy requirements. Broncholab provides physicians with reproducible CT values for pulmonary tissue for providing quantitative support for ...
ByFluidda
Milan, January 27, 2022 – InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announces the closing of its Series C financing with granting an exclusive licensing agreement to Grand Pharmaceutical Group Limited, (Grand Pharma) for its proprietary Saturn device in Greater China. ...
Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Nuance Pharma (“Nuance”), a specialty care focused biopharma with late-stage clinical programs and existing commercial operations, today announce an exclusive agreement to join forces in Greater China to develop a superior, non-invasive approach to treatment of RDS, a life-threatening ...
ByAerogen
We are continuing to set the standard of care by partnering with Spire to deploy Health Tags to our patients with chronic lung conditions,” said Larry Kay, CEO, Respiratory Care + Sleep Medicine. “Remote patient monitoring provides our team with insights into changes in our patients’ condition, giving us the opportunity to make impactful ...
Intin has been recognized for its outstanding design and engineering in healthcare technology. Diagnosis & treatment at home for respiratory conditions Intin's innovation not only diagnoses respiratory ailments but also helps get proper treatment. With the 'Oview Multi Device,' anyone can receive a diagnosis of ...
Daniel Motto, Enalare's Chief Operating Officer, will highlight how the successful partnership with BARDA is accelerating the development of Enalare's lead drug candidate ENA-001 as a potential treatment for respiratory depression in both mass casualty situations and the drug overdose epidemic. ...
US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance in connection with JCRI-ABTS’s US National Stage Application (Serial No. 17/284,762) entitled “SYSTEM FOR TREATMENT OF ...
These respiratory diseases require a precise determination of gas exchange to detect and treat these illnesses. ...
OM Pharma enters into a strategic collaboration agreement granting AstraZeneca the exclusive right to import and distribute the immunological therapy Broncho-Vaxom® for the prevention and treatment of respiratory tract infections in China (excluding Hong Kong, Macau, and Taiwan). ...
One of the tasks was to change the Samaria health station in the center of Espoo, Finland, into an infection center focusing on the treatment of respiratory infections. In the next phase, another health station was prepared for similar use in case the first infection center's capacity is reached. ...
On March 7th, YAGUO sent to Hubei a new set of respiratory devices, the number goes up to 100 devices worth around 2.2 million RMB, including bionic cough simulator (sputum removal system), respiratory dynamics (respiratory neuromuscular stimulator), and cuff pressure gauge (balloon manometers). ...
This new medical propellant has been under development for several years for use in metered-dose inhalers (MDIs) for treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). ...
ByKoura
Allovate Therapeutics (“Allovate®”), a New York-based biotechnology company focused on improving treatment for allergies, is pleased to announce the appointment of Robert "Bob" Pomrenke to the position of Chief Executive Officer, effective April 1, 2019. ...
Allovate Therapeutics, a biopharmaceutical company focused on improving treatment for allergies, announced today that the U.S Patent and Trademark Office (USPTO) has granted U.S. ...